Nasus Pharma (NSRX) Debt Ratio (2024)

Nasus Pharma (NSRX) reported Debt Ratio of 2.51 for Q4 2024.

Nasus Pharma (NSRX) Debt Ratio (2024) Analysis & Trends

Nasus Pharma has reported Debt Ratio for 1 years, with the latest figure at 2.51 in Q4 2024.

For the quarter ending Q4 2024, Debt Ratio changed N/A year-over-year to 2.51; the trailing twelve-month figure through Dec 2024 stood at 2.51 (changed N/A YoY), and the FY2024 full-year result was 2.51, changed N/A from the prior year.
Debt Ratio for Q4 2024 stood at 2.51.
The five-year high for Debt Ratio was 2.51 in Q4 2024, with the low at 2.51 in Q4 2024.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-0.22
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	0.37
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	0.27
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	0.47
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	0.38
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	0.62
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	0.39
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	0.31
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	0.51
10	Nasus Pharma	23.47 Mn	19.18 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2024	2.51